Literature DB >> 17254501

Trachoma: ancient scourge, disease elimination, and future research.

Charles Knirsch1.   

Abstract

Realistically, global elimination of trachoma could not have been considered until the maturation of innovation and public will that converged with the formation of both the Alliance for the Global Elimination of Trachoma by the year 2020 (GET2020) in 1997 and the public-private partnership, the International Trachoma Initiative (ITI) in 1998. Public-private partnerships are cross-sector collaborations that bring heterogeneous capabilities together to work on difficult problems for which the individual partners share common goals. The work of the ITI and partners to date demonstrates that the SAFE strategy reviewed in this article can work, and that it will revolutionize the control of blinding trachoma. Programs working to eliminate trachoma can achieve the GET2020 goals through expanded partnerships, commitment, and research on program integration into evolving health systems.

Entities:  

Year:  2007        PMID: 17254501     DOI: 10.1007/s11908-007-0018-z

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  41 in total

Review 1.  Can blinding trachoma be eliminated by 20/20?

Authors:  J Kumaresan
Journal:  Eye (Lond)       Date:  2005-10       Impact factor: 3.775

2.  Impact of community-based mass treatment for trachoma with oral azithromycin on general morbidity in Gambian children.

Authors:  C J Whitty; K W Glasgow; S T Sadiq; D C Mabey; R Bailey
Journal:  Pediatr Infect Dis J       Date:  1999-11       Impact factor: 2.129

3.  Sexually transmitted diseases treatment guidelines, 2006.

Authors:  Kimberly A Workowski; Stuart M Berman
Journal:  MMWR Recomm Rep       Date:  2006-08-04

4.  Using lot quality-assurance sampling and area sampling to identify priority areas for trachoma control: Viet Nam.

Authors:  Mark Myatt; Nguyen Phuong Mai; Nguyen Quang Quynh; Nguyen Huy Nga; Ha Huy Tai; Nguyen Hung Long; Tran Hung Minh; Hans Limburg
Journal:  Bull World Health Organ       Date:  2005-11-10       Impact factor: 9.408

5.  Field evaluation of a rapid point-of-care assay for targeting antibiotic treatment for trachoma control: a comparative study.

Authors:  Claude-Edouard C Michel; Anthony W Solomon; Jose P V Magbanua; Patrick A Massae; Ling Huang; Jonaice Mosha; Sheila K West; Elpidio C B Nadala; Robin Bailey; Craig Wisniewski; David C W Mabey; Helen H Lee
Journal:  Lancet       Date:  2006-05-13       Impact factor: 79.321

6.  Chlamydia trachomatis polymorphic membrane protein D is a species-common pan-neutralizing antigen.

Authors:  Deborah D Crane; John H Carlson; Elizabeth R Fischer; Patrik Bavoil; Ru-ching Hsia; Chun Tan; Cho-chou Kuo; Harlan D Caldwell
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-30       Impact factor: 11.205

7.  Single-dose azithromycin prevents trichiasis recurrence following surgery: randomized trial in Ethiopia.

Authors:  Sheila K West; Emily S West; Wondu Alemayehu; Muluken Melese; Beatriz Munoz; Alemush Imeru; Alemayehu Worku; Charlotte Gaydos; Curtis L Meinert; Thomas Quinn
Journal:  Arch Ophthalmol       Date:  2006-03

Review 8.  A critical review of the SAFE strategy for the prevention of blinding trachoma.

Authors:  Hannah Kuper; Anthony W Solomon; John Buchan; Marcia Zondervan; Allen Foster; David Mabey
Journal:  Lancet Infect Dis       Date:  2003-06       Impact factor: 25.071

9.  Risk of trachomatous scarring and trichiasis in Gambians varies with SNP haplotypes at the interferon-gamma and interleukin-10 loci.

Authors:  A Natividad; J Wilson; O Koch; M J Holland; K Rockett; N Faal; O Jallow; H M Joof; M J Burton; N D E Alexander; D P Kwiatkowski; D C W Mabey; R L Bailey
Journal:  Genes Immun       Date:  2005-06       Impact factor: 2.676

10.  Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study.

Authors:  Sheila K West; Beatriz Munoz; Harran Mkocha; Martin J Holland; Aura Aguirre; Anthony W Solomon; Allen Foster; Robin L Bailey; David C W Mabey
Journal:  Lancet       Date:  2005-10-08       Impact factor: 79.321

View more
  2 in total

1.  Integrated implementation of programs targeting neglected tropical diseases through preventive chemotherapy: proving the feasibility at national scale.

Authors:  Mary Linehan; Christy Hanson; Angela Weaver; Margaret Baker; Achille Kabore; Kathryn L Zoerhoff; Dieudonne Sankara; Scott Torres; Eric A Ottesen
Journal:  Am J Trop Med Hyg       Date:  2011-01       Impact factor: 2.345

2.  A cluster randomized study of the safety of integrated treatment of trachoma and lymphatic filariasis in children and adults in Sikasso, Mali.

Authors:  Yaya Ibrahim Coulibaly; Ilo Dicko; Modibo Keita; Mahamadou Minamba Keita; Moussa Doumbia; Adama Daou; Fadima Cheick Haidara; Moussa Hama Sankare; John Horton; Caroline Whately-Smith; Samba Ousmane Sow
Journal:  PLoS Negl Trop Dis       Date:  2013-05-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.